Deep Learning Features and Metabolic Tumor Volume Based on PET/CT to Construct Risk Stratification in Non-small Cell Lung Cancer DOI

Linjun Ju,

Wenbo Li, Rui Zuo

et al.

Academic Radiology, Journal Year: 2024, Volume and Issue: 31(11), P. 4661 - 4675

Published: May 12, 2024

Language: Английский

Impact of [18F]FDG PET/CT Radiomics and Artificial Intelligence in Clinical Decision Making in Lung Cancer: Its Current Role DOI Creative Commons

Alireza Safarian,

Seyed Ali Mirshahvalad,

Hadi Nasrollahi

et al.

Seminars in Nuclear Medicine, Journal Year: 2025, Volume and Issue: unknown

Published: March 1, 2025

Lung cancer remains one of the most prevalent cancers globally and leading cause cancer-related deaths, accounting for nearly one-fifth all fatalities. Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography ([18F]FDG PET/CT) plays a vital role in assessing lung managing disease progression. While traditional PET/CT imaging relies on qualitative analysis basic quantitative parameters, radiomics offers more advanced approach to analyzing tumor phenotypes. Recently, has gained attention its potential enhance prognostic diagnostic capabilities [18F]FDG various cancers. This review explores expanding PET/CT-based radiomics, particularly when integrated with artificial intelligence (AI), cancer, especially non-small cell (NSCLC). We how AI improve diagnostics, staging, subtype identification, molecular marker detection, which influence treatment decisions. Additionally, we address challenges clinical integration, such as protocol standardization, feature reproducibility, need extensive prospective studies. Ultimately, hold great promise enabling personalized effective treatments, potentially transforming management.

Language: Английский

Citations

5

Patients’ attitudes toward artificial intelligence (AI) in cancer care: A scoping review protocol DOI Creative Commons

Daniel Hilbers,

Navid Nekain,

Alan Bates

et al.

PLoS ONE, Journal Year: 2025, Volume and Issue: 20(1), P. e0317276 - e0317276

Published: Jan. 14, 2025

Background Artificial intelligence broadly refers to computer systems that simulate intelligent behaviour with minimal human intervention. Emphasizing patient-centered care, research has explored patients’ perspectives on artificial in medical indicating general acceptance of the technology but also concerns about supervision. However, these views have not been systematically examined from perspective patients cancer, whose opinions may differ given distinct psychosocial toll disease. Objectives This protocol describes a scoping review aimed at summarizing existing literature attitudes cancer toward use their care. The primary goal is identify knowledge gaps and highlight opportunities for future research. Methods will adhere Preferred Reporting Items Systematic Reviews Meta-Analyses guidelines (PRISMA-ScR). electronic databases MEDLINE (OVID), EMBASE, PsycINFO, CINAHL be searched peer-reviewed articles published academic journals. We two independent reviewers screen retrieved search select relevant studies based our inclusion criteria, third reviewer resolving any disagreements. then compile data included into narrative summary discuss implications clinical practice Discussion To knowledge, this first map regarding

Language: Английский

Citations

1

Artificial intelligence-assisted point-of-care devices for lung cancer DOI
Xinyi Ng, Anis Salwa Mohd Khairuddin,

Hai Chuan Liu

et al.

Clinica Chimica Acta, Journal Year: 2025, Volume and Issue: unknown, P. 120191 - 120191

Published: Feb. 1, 2025

Language: Английский

Citations

1

Machine Learning and Texture Analysis of [18F]FDG PET/CT Images for the Prediction of Distant Metastases in Non-Small-Cell Lung Cancer Patients DOI Creative Commons
Armin Hakkak Moghadam Torbati, Sara Pellegrino, Rosa Fonti

et al.

Biomedicines, Journal Year: 2024, Volume and Issue: 12(3), P. 472 - 472

Published: Feb. 20, 2024

The aim of our study was to predict the occurrence distant metastases in non-small-cell lung cancer (NSCLC) patients using machine learning methods and texture analysis 18F-labeled 2-deoxy-d-glucose Positron Emission Tomography/Computed Tomography {[18F]FDG PET/CT} images. In this retrospective single-center study, we evaluated 79 with advanced NSCLC who had undergone [18F]FDG PET/CT scan at diagnosis before any therapy. Patients were divided into two independent training (n = 44) final testing 35) cohorts. Texture features primary tumors lymph node extracted from images LIFEx program. Six applied dataset entire panel features. Dedicated selection used generate different combinations five performance selected determined accuracy, confusion matrix, receiver operating characteristic (ROC) curves, area under curve (AUC). A total 104 78 lesions analyzed cohorts, respectively. support vector (SVM) decision tree showed highest accuracy cohort. Seven obtained introduced models subsequently cohorts SVM tree. AUC method higher than those best combination included shape sphericity, gray level run length matrix_run non-uniformity (GLRLM_RLNU), Total Lesion Glycolysis (TLG), Metabolic Tumor Volume (MTV), compacity. these could an 74.4% 0.63 patients.

Language: Английский

Citations

7

Machine learning-based exosome profiling of multi-receptor SERS sensors for differentiating adenocarcinoma in situ from early-stage invasive adenocarcinoma DOI
Dechan Lu, Bohan Zhang,

Zhikun Shangguan

et al.

Colloids and Surfaces B Biointerfaces, Journal Year: 2024, Volume and Issue: 236, P. 113824 - 113824

Published: Feb. 24, 2024

Language: Английский

Citations

6

Unravelling the diagnostic pathology and molecular biomarkers in lung cancer DOI Open Access
Andriani Charpidou,

Georgia Hardavella,

Efimia Boutsikou

et al.

Breathe, Journal Year: 2024, Volume and Issue: 20(2), P. 230192 - 230192

Published: June 1, 2024

The progress in lung cancer treatment is closely interlinked with the diagnostic methods. There are four steps before commencing treatment: estimation of patient's performance status, assessment disease stage (tumour, node, metastasis), recognition histological subtype, and detection biomarkers. resection rate <30% >70% patients need systemic therapy, which individually adjusted. Accurate diagnosis very important it basis further molecular diagnosis. In many cases only small biopsy samples available rules for their defined this review. use immunochemistry at least thyroid transcription factor 1 (TTF1) p40 decisive distinction between adenocarcinoma squamous cell carcinoma. Molecular known driver mutations necessary introducing targeted therapy multiplex gene panel assays using next-generation sequencing recommended. Immunotherapy checkpoint inhibitors second promising method best results tumours high programmed death-ligand (PD-L1) expression on cells. Finally, determination a full tumour pattern will be possible artificial intelligence near future.

Language: Английский

Citations

4

The Biomedical Applications of Artificial Intelligence: An Overview of Decades of Research DOI

Sweet Naskar,

Suraj Sharma, Ketousetuo Kuotsu

et al.

Journal of drug targeting, Journal Year: 2025, Volume and Issue: unknown, P. 1 - 85

Published: Jan. 2, 2025

A significant area of computer science called artificial intelligence (AI) is successfully applied to the analysis intricate biological data and extraction substantial associations from datasets for a variety biomedical uses. AI has attracted interest in research due its features: (i) better patient care through early diagnosis detection; (ii) enhanced workflow; (iii) lowering medical errors; (v) costs; (vi) reducing morbidity mortality; (vii) enhancing performance; (viii) precision; (ix) time efficiency. Quantitative metrics are crucial evaluating implementations, providing insights, enabling informed decisions, measuring impact AI-driven initiatives, thereby transparency, accountability, overall impact. The implementation fields faces challenges such as ethical privacy concerns, lack awareness, technology unreliability, professional liability. brief discussion given techniques, which include Virtual screening (VS), DL, ML, Hidden Markov models (HMMs), Neural networks (NNs), Generative (GMs), Molecular dynamics (MD), Structure-activity relationship (SAR) models. study explores application fields, highlighting predictive accuracy, treatment efficacy, diagnostic efficiency, faster decision-making, personalized strategies, precise interventions.

Language: Английский

Citations

0

One Scan, Multiple Insights: A Review of AI-Driven Biomarker Imaging and Composite Measure Detection in Lung Cancer Screening DOI Creative Commons

Sunil Verma,

Leander Maerkisch, Alberto Paderno

et al.

Meta-Radiology, Journal Year: 2025, Volume and Issue: unknown, P. 100124 - 100124

Published: Jan. 1, 2025

Language: Английский

Citations

0

Retrospective Analysis Comparing Lung-RADS v2022 and British Thoracic Society Guidelines for Differentiating Lung Metastases from Primary Lung Cancer DOI Creative Commons

Loredana Gabriela Stana,

Ovidiu Alexandru Mederle, Claudiu Avram

et al.

Biomedicines, Journal Year: 2025, Volume and Issue: 13(1), P. 130 - 130

Published: Jan. 8, 2025

Background and Objectives: The current study aimed to compare the effectiveness of Lung Imaging Reporting Data System (Lung-RADS) Version 2022 British Thoracic Society (BTS) guidelines in differentiating lung metastases from de novo primary cancer on CT scans patients without prior diagnosis. Materials Methods: This retrospective included 196 who underwent chest between 2015 a known history but with detected pulmonary nodules. images characterized nodules based size, number, location, margins, attenuation, growth patterns. Nodules were classified according Lung-RADS BTS guidelines. Statistical analyses compared sensitivity specificity distinguishing cancer. Subgroup conducted nodule characteristics. Results: Of patients, 148 (75.5%) had cancer, 48 (24.5%) occult tumors. demonstrated higher than (87.2% vs. 72.3%, p < 0.001) while maintaining similar (91.7% 93.8%, = 0.68) more likely present multiple (81.3% 18.2%, 0.001), lower lobe distribution (58.3% 28.4%, smooth margins (70.8% 20.3%, whereas cancers associated solitary nodules, upper spiculated margins. Conclusions: provides Recognizing characteristic imaging features can improve diagnostic accuracy guide appropriate management.

Language: Английский

Citations

0

Lung cancer screening in India: Preparing for the future using smart tools & biomarkers to identify highest risk individuals DOI Open Access

Nithya Ramnath,

Prasanth Ganesan, Prasanth Penumadu

et al.

The Indian Journal of Medical Research, Journal Year: 2025, Volume and Issue: 160, P. 561 - 569

Published: Jan. 15, 2025

There is a growing burden of lung cancer cases in India, incidence projected to increase from 63,708 (2015) 81,219 (2025). The increasing numbers are attributed smoking (India currently has nearly 100 million adult smokers) and environmental pollution. Most patients present with advanced disease (80-85% incurable), causing 60,000 annual deaths cancer. Early detection through screening (LCS) can result curative therapies for earlier stages improved survival. Annual low-dose computerized tomography (LDCT) the standard method LCS. Usually, high-risk populations (age>50 yr >20 pack-years smoking) considered LCS, but even such focused may be challenging resource-limited countries like India. However, developing smart LCS programme high yield possible by leveraging demographic genomic data, use tools, judicious blood-based biomarkers. Developing this model over next several years will facilitate structured at highest risk In paper, we discuss demographics India its relation patterns. Further, elaborate on potential applications challenges bringing approach

Language: Английский

Citations

0